Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy (Q36541094)
Jump to navigation
Jump to search
scientific article published on 18 July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy |
scientific article published on 18 July 2006 |
Statements
1 reference
Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy (English)
1 reference
Andrew P Levy
1 reference
18 July 2006
1 reference
1 reference
Identifiers
1 reference